Central Bancompany, Inc.: Form 10-Q for the period ended Mar 31, 2026
Filed with the SEC on May 15, 2026 and accepted by EDGAR at May 15, 2026, 14:36 ET.
Management's discussion and analysis
As filed, 2,047 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
The following table presents information regarding issuer purchases of equity securities during the first quarter of 2026.
| Period | Total Number Of Shares Purchased (1)(2) | Average Price Paid Per Share | Total Number Of Shares Purchased As Part Of Publicly Announced Plans Or Programs2 | Approximate Dollar Value of Shares That May Yet Be Purchased Under the Plans or Programs |
|---|---|---|---|---|
| January 1 - January 31, 2026 | - | $- | - | $- |
| February 1 - February 28, 2026 | 93,925 | 24.34 | 93,925 | 47,714,160.90 |
| March 1 - March 31, 2026 | 1,222,583 | 24.00 | 1,202,324 | 18,857,084.24 |
| Total | 1,316,508 | $24.03 | 1,296,249 | |
| (1) Includes 20,259 shares acquired pursuant to the Central Bancompany, Inc. Restricted Stock Plan approved by the Board on February 13, 2023 ("RSA Plan"). Pursuant to the terms of the Company's RSA Plan, the Company accepts previously owned shares of common stock surrendered to satisfy tax withholding obligations associated with equity compensation. These purchases do not count against the maximum value of shares remaining available for purchase under the 2026 Repurchase Plan. | ||||
| (2) Includes shares acquired under the Board of Directors approved 2026 Repurchase Plan. |
On February 4, 2026, the Board of Directors of the Company approved the Company to repurchase of up to $50 million of shares of the Company’s Class A common stock (the “2026 Repurchase Plan”). This 2026 Repurchase Plan authorization replaces and supersedes the Company’s prior authorizations.
The Company has not made any repurchases other than through the 2026 Repurchase Plan, but did acquire shares pursuant to the Company's RSA Plan. All share purchases pursuant to the 2026 Repurchase Plan are intended to be within the scope of Rule 10b-18 promulgated under the Exchange Act. Rule 10b-18 provides a safe harbor for certain purchases if the Company satisfies the manner, timing, price and volume conditions of the rule when purchasing its own shares of common stock.
Market risk
As filed, 326 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There have been no material changes in the Company’s market risk from those disclosed in the Company’s Annual Report on Form 10‑K for the year ended December 31, 2025. For additional information, see “Management’s Discussion and Analysis of Financial Condition and Results of Operations” in this Quarterly Report on Form 10‑Q.
Controls and procedures
As filed, 1,466 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Evaluation of Disclosure Controls and Procedures
Our management, with the participation of our Chief Executive Officer and our Chief Financial Officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), as of the end of this period covered by this report. Based on such evaluation, our Chief Executive Officer and Chief Financial Officer have concluded that, as of the end of such period, the Company’s disclosure controls and procedures were effective to provide reasonable assurance that the information required to be disclosed by the Company in the reports it files or submits under the Exchange Act is recorded, processed, summarized, and reported within the time periods specified in the rules and forms of the SEC and that such information is accumulated and communicated to Company’s management, including its Chief Executive Officer and its Chief Financial Officer, as appropriate, to allow timely decisions regarding required disclosure.
Changes in Internal Control Over Financial Reporting
There have not been any changes in the Company’s internal control over financial reporting (as defined in Rule 13a 15(f) under the Exchange Act) during the fiscal quarter ended March 31, 2026 that have materially affected, or are reasonably likely to materially affect, the Company’s internal control over financial reporting.
Risk factors
As filed, 148 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There have been no material changes to the risk factors previously disclosed in our Annual Report on Form 10-K for the year ended December 31, 2025.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2026-03-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Income tax | 3 months2026-01-01 to 2026-03-31 | $32.9m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2026-01-01 to 2026-03-31 | $111.1m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2026-01-01 to 2026-03-31 | $0.46 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2026-01-01 to 2026-03-31 | $0.46 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2026-01-01 to 2026-03-31 | 240,637,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 3 months2026-01-01 to 2026-03-31 | $210.1m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 3 months2026-01-01 to 2026-03-31 | $8.4m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 3 months2026-01-01 to 2026-03-31 | $29.1m | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 3 months2026-01-01 to 2026-03-31 | $31.1m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Total assets | At period end2026-03-31 | $20.46bn | us-gaap:Assets |
| Total liabilities | At period end2026-03-31 | $16.66bn | us-gaap:Liabilities |
| Shareholders' equity | At period end2026-03-31 | $3.80bn | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001628280-26-035492. Last ingested by Listed: Nov 2, 2026, 19:38 ET. Listed shows no prices and gives no investment advice.